Copyright
©The Author(s) 2024.
World J Gastroenterol. Jun 14, 2024; 30(22): 2902-2919
Published online Jun 14, 2024. doi: 10.3748/wjg.v30.i22.2902
Published online Jun 14, 2024. doi: 10.3748/wjg.v30.i22.2902
Figure 1 Management of loss of response to vedolizumab.
PNR: Primary non-response; LOR: Loss of response.
- Citation: Vootukuru N, Vasudevan A. Approach to loss of response to advanced therapies in inflammatory bowel disease. World J Gastroenterol 2024; 30(22): 2902-2919
- URL: https://www.wjgnet.com/1007-9327/full/v30/i22/2902.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i22.2902